-
Something wrong with this record ?
Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease
JD. Clarke, P. Novak, AD. Lake, RN. Hardwick, NJ. Cherrington,
Language English Country United States
Document type Journal Article, Research Support, N.I.H., Extramural
PubMed
28097795
DOI
10.1111/liv.13362
Knihovny.cz E-resources
- MeSH
- Biological Transport MeSH
- Endoplasmic Reticulum metabolism MeSH
- Glycosylation MeSH
- Liver metabolism MeSH
- Humans MeSH
- Membrane Transport Proteins genetics metabolism MeSH
- Non-alcoholic Fatty Liver Disease diagnosis genetics metabolism MeSH
- Protein Processing, Post-Translational * MeSH
- Gene Expression Profiling MeSH
- Case-Control Studies MeSH
- Transcriptome MeSH
- Blotting, Western MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, N.I.H., Extramural MeSH
BACKGROUND & AIMS: N-linked glycosylation of proteins is critical for proper protein folding and trafficking to the plasma membrane. Drug transporters are one class of proteins that have reduced function when glycosylation is impaired. N-linked glycosylation of plasma proteins has also been investigated as a biomarker for several liver diseases, including non-alcoholic fatty liver disease (NAFLD). The purpose of this study was to assess the transcriptomic expression of genes involved in protein processing and glycosylation, and to determine the glycosylation status of key drug transporters during human NAFLD progression. METHODS: Human liver samples diagnosed as healthy, steatosis, and non-alcoholic steatohepatitis (NASH) were analysed for gene expression of glycosylation-related genes and for protein glycosylation using immunoblot. RESULTS: Genes involved in protein processing in the ER and biosynthesis of N-glycans were significantly enriched for down-regulation in NAFLD progression. Included in the down regulated N-glycan biosynthesis category were genes involved in the oligosaccharyltransferase complex, N-glycan quality control, N-glycan precursor biosynthesis, N-glycan trimming to the core, and N-glycan extension from the core. N-glycan degradation genes were unaltered in the progression to NASH. Immunoblot analysis of the uptake transporters organic anion transporting polypeptide-1B1 (OATP1B1), OATP1B3, OATP2B1, and Sodium/Taurocholate Co-transporting Polypeptide (NTCP) and the efflux transporter multidrug resistance-associated protein 2 (MRP2) demonstrated a significant loss of glycosylation following the progression to NASH. CONCLUSIONS: These data suggest that the loss of glycosylation of key uptake and efflux transporters in humans NASH may influence transporter function and contribute to altered drug disposition observed in NASH.
Biology Centre ASCR Institute of Plant Molecular Biology Ceske Budejovice Czech Republic
Department of Pharmacology and Toxicology University of Arizona Tucson AZ USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025189
- 003
- CZ-PrNML
- 005
- 20180717085423.0
- 007
- ta
- 008
- 180709s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/liv.13362 $2 doi
- 035 __
- $a (PubMed)28097795
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Clarke, John D $u Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.
- 245 10
- $a Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease / $c JD. Clarke, P. Novak, AD. Lake, RN. Hardwick, NJ. Cherrington,
- 520 9_
- $a BACKGROUND & AIMS: N-linked glycosylation of proteins is critical for proper protein folding and trafficking to the plasma membrane. Drug transporters are one class of proteins that have reduced function when glycosylation is impaired. N-linked glycosylation of plasma proteins has also been investigated as a biomarker for several liver diseases, including non-alcoholic fatty liver disease (NAFLD). The purpose of this study was to assess the transcriptomic expression of genes involved in protein processing and glycosylation, and to determine the glycosylation status of key drug transporters during human NAFLD progression. METHODS: Human liver samples diagnosed as healthy, steatosis, and non-alcoholic steatohepatitis (NASH) were analysed for gene expression of glycosylation-related genes and for protein glycosylation using immunoblot. RESULTS: Genes involved in protein processing in the ER and biosynthesis of N-glycans were significantly enriched for down-regulation in NAFLD progression. Included in the down regulated N-glycan biosynthesis category were genes involved in the oligosaccharyltransferase complex, N-glycan quality control, N-glycan precursor biosynthesis, N-glycan trimming to the core, and N-glycan extension from the core. N-glycan degradation genes were unaltered in the progression to NASH. Immunoblot analysis of the uptake transporters organic anion transporting polypeptide-1B1 (OATP1B1), OATP1B3, OATP2B1, and Sodium/Taurocholate Co-transporting Polypeptide (NTCP) and the efflux transporter multidrug resistance-associated protein 2 (MRP2) demonstrated a significant loss of glycosylation following the progression to NASH. CONCLUSIONS: These data suggest that the loss of glycosylation of key uptake and efflux transporters in humans NASH may influence transporter function and contribute to altered drug disposition observed in NASH.
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a endoplazmatické retikulum $x metabolismus $7 D004721
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a glykosylace $7 D006031
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a membránové transportní proteiny $x genetika $x metabolismus $7 D026901
- 650 _2
- $a nealkoholová steatóza jater $x diagnóza $x genetika $x metabolismus $7 D065626
- 650 12
- $a posttranslační úpravy proteinů $7 D011499
- 650 _2
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Novak, Petr $u Biology Centre ASCR, Institute of Plant Molecular Biology, Ceske Budejovice, Czech Republic.
- 700 1_
- $a Lake, April D $u Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.
- 700 1_
- $a Hardwick, Rhiannon N $u Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.
- 700 1_
- $a Cherrington, Nathan J $u Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.
- 773 0_
- $w MED00007623 $t Liver international official journal of the International Association for the Study of the Liver $x 1478-3231 $g Roč. 37, č. 7 (2017), s. 1074-1081
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28097795 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180717085722 $b ABA008
- 999 __
- $a ok $b bmc $g 1317320 $s 1022110
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 37 $c 7 $d 1074-1081 $e 20170207 $i 1478-3231 $m Liver international $n Liver Int $x MED00007623
- LZP __
- $a Pubmed-20180709
